SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after the financial ...

Health enthusiasts and biohackers are shifting toward plant-based, glucose-regulating supplements that focus on holistic wellness. Products like Sugar Defender are catching attention because they ...

RBC Capital lowered the firm’s price target on Tandem Diabetes (TNDM) to $45 from $55 and keeps an Outperform rating on the shares as part of a ...

Fintel reports that on April 10, 2025, Mizuho initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a Neutral ...

Try Now>> See today’s best-performing stocks on TipRanks >> Read More on TNDM: Disclaimer & Disclosure Report an Issue Tandem Diabetes Care NewsMORE Related Stocks Indices Commodities Currencies ...

With technology that automatically adjusts insulin delivery based on continuous glucose monitoring data, Tandem Diabetes Care (NASDAQ:TNDM) develops and manufactures automated insulin delivery ...

Across the recent three months, 9 analysts have shared their insights on Tandem Diabetes Care TNDM, expressing a variety of opinions spanning from bullish to bearish. The table below offers a ...

Fintel reports that on April 10, 2025, Mizuho initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a Neutral recommendation. As of April 2, 2025, the average one-year price target for ...